pd 138312 has been researched along with Bacterial Infections, Gram-Positive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, MA; Courtney, CL; Huband, MD; Roland, GE; Yoder, SL | 1 |
| Dever, JA; Joannides, ET; Sesnie, JC; Shapiro, MA; Vanderroest, SR | 1 |
2 other study(ies) available for pd 138312 and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1995 |
In vivo therapeutic efficacies of PD 138312 and PD 140248, two novel fluoronaphthyridines with outstanding gram-positive potency.
Topics: Animals; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacterial Infections; Mice; Naphthyridines; Pneumonia, Pneumococcal | 1995 |